Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Stora Enso interim report January–September 2017

Solid performance: A step change in our transformationSTORA ENSO OYJ, Helsinki, FinlandINTERIM REPORT 25 October 2017 at 9.30 EESTQ3/2017 (year-on-year) · Sales of EUR 2 509 (EUR 2 393) million increased 4.8%: the third consecutive quarter of sales growth. · Sales excluding the paper business increased 11.1%. · Operational EBIT increased 32.4% to EUR 290 (EUR 219) million. This was mainly due to favourable sales prices and increased volumes from the recent strategic investments, and good cost management. · Balance sheet continued strengthening; net debt to operational

UPM receives an A score for CDP's Water and Forests Programs

(UPM, Helsinki, 25 October 2017 at 09.30 EET)  - UPM has been positioned on this year's A List for water and forests by CDP, the non-profit global environmental disclosure platform. CDP's A List comprises companies from around the world that have been identified as leading in their efforts and actions to combat environmental risk in the past CDP reporting year. Of the companies that submitted information, UPM is one of the only four companies to score an A on both water and forests. "UPM is committed to the internationally accepted principles of sustainable forest management

Stora Enso invests EUR 94 million to grow in renewable materials

STORA ENSO OYJ INVESTOR NEWS 25 October 2017 at 9.29 EESTStora Enso will invest EUR 94 million to grow in renewable materials and to increase competitiveness in consumer board and biomaterials. EUR 52 million will be invested to increase the dissolving pulp production capacity at Enocell Mill and EUR 42 million to enhance the availability of the chemi-thermomechanical pulp (CTMP) at Imatra Mills. Both mills are located in Finland.“We continue to drive our transformation to a renewable materials growth company. While investing in our Finnish mills, we expect the competitiveness of Finland’

Innovative solutions in focus at Gränges’ sixth India Technical Seminar

Gränges India Technical Seminar 2017 takes place on October 25-26, 2017, in Pune, India. The seminar is arranged every second year and 2017 is the sixth event since the start in 2007. Approximately 80 of the company’s largest customers and business partners in the region are attending the seminar.India is one of the fastest growing markets in the world when it comes to production of light vehicles, and is expected to grow by more than 8 per cent annually[1] to 2022. This year’s seminar will focus on the requirements and challenges in the emerging Indian automotive industry and how this will

Hexagon launches requalification testing program to improve customer value and minimize downtime

Hexagon Composites' subsidiary Hexagon Lincoln, with its partner Digital Wave Corporation launch requalification testing program for its Mobile Pipeline® modules. The efficient requalification technology minimizes the operators' out of service time while ensuring an approved, safe and reliable requalification method. In 2012, Hexagon's first TITAN® modules to the North American market were delivered to customers for delivering compressed natural gas. As part of the U.S. DOT (Department of Transport) approval of TITAN®, the operators of the modules are required to requalify the cylinders

Previous screening results important for decision about smear tests after age 60

[PRESS RELEASE, 25 OCT. 2017] Being screened again after the age of 60 reduces the risk of cervical cancer in women who have previously had abnormal smear tests and in women who did not have smear tests in their 50s, researchers at Karolinska Institutet in Sweden show. The study, which is published in PLOS Medicine, is important for setting guidelines on the age at which screening can be discontinued.Despite being screened with gynaecological smear tests, relatively many women over the age of 60 develop cervical cancer. There is currently a discussion on when and against what criteria

Alprolix® approved in the Kingdom of Saudi Arabia for the treatment of haemophilia B

Swedish Orphan Biovitrum AB (publ)  (Sobi™) today announces that the Saudi Food & Drug Authority (SFDA) in the Kingdom of Saudi Arabia has approved Alprolix® (eftrenonacog alfa), for the treatment of haemophilia B.  Alprolix is the first extended half-life and recombinant factor IX Fc fusion protein therapy approved for the treatment of haemophilia B in Saudi Arabia. “We are very pleased Alprolix is now approved in Saudi Arabia, which will enable physicians to offer their patients with haemophilia B a wider range of treatment options and the opportunity to

Finnair’s expansion to reach all-time high during winter season – new routes opening to India, Mexico, Cuba, Dominican Republic and Lapland

Finnair is poised to enter the largest expansion in its history during the upcoming winter season. With its fast-connecting hub in Helsinki, Finnair offers one of the most reliable and convenient networks linking several key destinations in Europe with Asia and North America. Finnair’s growth strategy will be in full swing during the winter season with 20 intercontinental destinations, over 100 destinations in Europe and a significant increase in capacity for Lapland destinations. Finnair is opening new routes to Goa, India on November 1, to Puerto Vallarta, Mexico on November 5, to

Finnair’s financial calendar and AGM in 2018

Finnair Plc    Stock Exchange Release     25 October 2017 at 9.05 EET Finnair Plc will publish four financial reviews in 2018. The publication dates are as follows:Financial Statements Bulletin for 2017 on Friday 16 February 2018Interim Report for January–March 2018 on Wednesday 25 April 2018Half-Year Report for January–June 2018 on Tuesday 17 July 2018Interim Report for January–September 2018 on Thursday 25 October 2018The financial statements bulletin and interim reports in 2017 will be published at approximately 9:00 am EET.Finnair’s Financial Statements, Report of the

Greenbyte releases an infographic on renewable energy in France

Renewable energy software company Greenbyte releases a series of infographics on renewable energy production in the European Union. After covering Germany and the UK, it is time to take a closer look at the renewable electricity generation in France.The infographic focuses on data for wind, solar and hydro and sheds light on today’s renewable energy market as well as its evolution in Europe over the past 10 years. “We conducted an analysis of the European renewable energy market for internal purposes and quickly realized that our findings could be of interest not only to our customers

Gunnebo Interim Report January-September 2017

Comments on the third quarter by Gunnebo’s President and CEO, Henrik Lange As announced in a press release on October 8, the Group reported a weaker operating profit for the third quarter of 2017 than for the corresponding quarter of the previous year, MSEK 49 (91). However, development has been different across the business. Region Asia-Pacific had organic sales growth of 9% for the quarter. At the same time, organic sales decreased by 5% in Region EMEA and in Region Americas it remained unchanged. Excluding France, EMEA had negative organic growth of 3% and the Group as a whole

Alligator Bioscience AB Interim Report January-September 2017

Three important collaborations in place. Results in November from ADC-1013 clinical phase I study.Significant events, July-September• Aptevo Therapeutics and Alligator Bioscience signed a co-development agreement on the bispecific antibody ALG.APV-527. Preclinical development and initial production activities for clinical trial materials for ALG.APV-527 commenced. • The immuno-oncology collaboration with Stanford University was expanded. The aim is to predict the clinical efficacy of Alligator’s pipeline candidates using biomarkers. • A research contract was signed with Professor

Interim report January - September 2017: Good growth continues and successful rights issue

Third quarter · Order intake increased by 12% to 297.4 MSEK (266.3). · Net sales increased by 7% to 289.1 MSEK (271.1). · EBIT was 5.6 MSEK (4.7). · Profit/loss after tax was -2.2 MSEK (-72.7 including impairment loss on shares in associated companies of 71.6 MSEK). · Earnings per share were -0.09 SEK (-2.55). · 225 MSEK rights issue completed on 6 October.    Nine months · Order intake increased by 14% to 922.1 MSEK (811.4). · Net sales rose by 6% to 883.3 MSEK (834.9).  · EBIT was 14.6 MSEK (-46.6). Year-2016 earnings were charged with non-recurring

Clavister Revenues rise 52% alongside a Gross Profit increase of 81% Year over Year

The Q3 2017 report shows substantial improvements in various aspects of the business. Orders from key strategic customers, including one of the world’s largest mobile operators, have been received during the quarter.Clavister (Nasdaq: CLAV), a leader in high-performance network security solutions, released its latest quarterly report detailing increases in most of its key metrics including revenues (+52%), gross margin (+12 percentage points), and gross profit (+81%) year over year. It also detailed growth in main enterprise geographical markets such as the Nordics (+74%), EMEA excluding

Alimak Group: Interim report January – September 2017

Continued good growth for the Group despite a slower quarter in Construction   · Increased EBITA, revenue and order intake on group level · EBITA impacted by a one-time MSEK 17 non-cash PPA adjustment* · Integration running according to plan and solid contribution on order intake and revenues from acquired businesses Third quarter · Order intake increased by 70% to MSEK 869 (512) with organic growth of 7% · Revenue increased by 108% to MSEK 980 (471) with organic growth of 6% · EBITA adj. increased to MSEK 101 (73), margin 10.3% (15.5) negatively impacted by a non-

Exel Composites Plc’s January–September Business Review 2017: “Adjusted operating profit almost tripled in Q3 2017”

EXEL COMPOSITES PLC      STOCK EXCHANGE RELEASE     25 OCTOBER 2017 at 09:00 EETQ3 2017 in brief ·  Order intake increased by 5.9% to EUR 19.3 million (Q3 2016: 18.2). ·  Revenue increased by 24.1% to EUR 20.4 million (16.4). ·  Adjusted operating profit improved to EUR 1.6 million (0.6), which is 7.9% of revenue (3.6%). ·  Net cash flow from operating activities was EUR 2.1 million (2.5). ·  Earnings per share amounted to EUR 0.09 (0.03). Q1-Q3 2017 in brief ·  Order intake increased by 15.2% to EUR 65.1 million (56.5). ·  Revenue increased by 18.1% to EUR 63.8

Nordnet Interim Report January–September 2017

July – September 2017 • Operating income increased by 0.2 percent to SEK 290.3 million (289.6)• Operating profit decreased by 40 percent to SEK 50.6 million (84.0)• Profit after tax for the period fell by 37 percent to SEK 43.4 million (69.2).• The building of the new Nordnet has commenced, with extraordinary expenses in the third quarter amounting to  SEK 5.6 million January – September 2017 • Operating income increased by 3 percent to SEK 911.0 million (882.0)• Operating profit decreased by 26 percent to SEK 193.3 million (260.0)• Profit after tax for the period fell

Interim report Q3, July – September 2017

• Net sales for the quarter increased by 17.1 per cent to SEK 1,505m (1,285), including a negative impact of exchange rates of –0.4 per cent. Organic growth was –2.8 per cent. • Operating profit amounted to SEK 169m (195). Operating profit, adjusted amounted to SEK 169m (203). • Cash flow from operating activities amounted to SEK 135m (116). • Net debt/EBITDA ratio was 2.63x (2.76). • Cloetta Italia S.r.l. was sold to Katjes International GmbH on 5 September 2017. This information constituted before the publication inside information and is such that Cloetta AB (publ) is

President and CEO Henri de Sauvage-Nolting comments on the results for the third quarter of 2017

The third quarter has been challenging, mainly due to the consequences from a fire on a production line in the factory in Turnhout, Belgium. This has created ripple effects such as production capacity constraints in our factory network, which has to some extent been compensated by additional shifts in other factories and outsourced volumes. In total, this has resulted in lower production volumes and higher production costs. In addition, organic sales have continued to decline, mainly due to specific challenges in a few markets.The damaged line at the factory in Turnhout will be replaced by

Ovako publishes its report for the third quarter 2017

Today Ovako announced its result for the third quarter 2017. EBITDA before restructuring costs improved to EUR 9 (5) million. Sales volume during the quarter amounted to 162 kton, 11 percent higher than previous year. Order intake increased by 14 percent, while the order book was more than 50 percent higher compared to corresponding time last year. Cash flow from operating activities improved from EUR 3 to 14 million. Ovako’s restructuring program has delivered savings of EUR 4 million during the quarter.Third quarter 2017 (2016)   · Order intake increased by 14 percent compared to the

Read original

Evolution Gaming: Interim report January-September 2017

Third quarter of 2017 (Q3 2016)  · Operating revenues increased by 56% to EUR 45.7 million (29.2) · EBITDA increased by 103% to EUR 21.8 million (10.8), corresponding to a margin of 47.7% (36.8) · Profit for the period amounted to EUR 16.8 million (7.4) · Earnings per share amounted to EUR 0.47 (0.21) January-September 2017 (9m 2016)  · Operating revenues increased by 57% to EUR 127.7 million (81.1) · EBITDA increased by 83% to EUR 58.0 million (31.7), corresponding to a margin of 45.5% (39.0) · Profit for the period amounted to EUR 44.1 million (22.7) ·

There are no items matching the current filter
There are no more items matching the current filter
Back to top